Clinical Trial Update: Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Zifibancimig in participants with Neovascular Age-Related Macular Degeneration. The Phase 1/2 study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Zifibancimig

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Macular Degeneration | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING